Beta Bionics, Inc. — All Filings
203 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
144
144/A
3
4
4/A
424B4
8-A12B
8-K
C
C-AR
C-AR/A
C-U
C/A
CERT
CORRESP
D
D/A
DRS
DRS/A
DRSLTR
EFFECT
S-1
S-1/A
S-1MEF
S-3ASR
S-8
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | FORM 8-K | 0001171843-25-002817 | May 6, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-064504 | May 6, 2025 | Mar 31, 2025 |
| SCHEDULE 13G | — | 0001213900-25-039260 | May 2, 2025 | — |
| SCHEDULE 13G | — | 0000904454-25-000219 | Apr 9, 2025 | — |
| 10-K/A | 10-K/A | 0000950170-25-046762 | Mar 28, 2025 | Dec 31, 2024 |
| 4 | — | 0001415889-25-009123 | Mar 27, 2025 | Mar 26, 2025 |
| 3 | — | 0001415889-25-009122 | Mar 27, 2025 | Mar 26, 2025 |
| 8-K | FORM 8-K | 0001171843-25-001785 | Mar 27, 2025 | Mar 26, 2025 |
| 10-K | 10-K | 0000950170-25-044516 | Mar 25, 2025 | Dec 31, 2024 |
| 8-K | FORM 8-K | 0001171843-25-001690 | Mar 25, 2025 | — |
| 4 | — | 0001415889-25-008534 | Mar 18, 2025 | Mar 15, 2025 |
| 4 | — | 0001415889-25-008533 | Mar 18, 2025 | Mar 15, 2025 |
| 4 | — | 0001415889-25-008537 | Mar 18, 2025 | Mar 15, 2025 |
| 4 | — | 0001415889-25-008536 | Mar 18, 2025 | Mar 15, 2025 |
| 4 | — | 0001415889-25-008535 | Mar 18, 2025 | Mar 15, 2025 |
| 4 | — | 0001415889-25-006232 | Mar 3, 2025 | Feb 27, 2025 |
| 4 | — | 0001415889-25-006233 | Mar 3, 2025 | Feb 27, 2025 |
| 4 | — | 0001415889-25-006231 | Mar 3, 2025 | Feb 27, 2025 |
| 4 | — | 0001415889-25-006230 | Mar 3, 2025 | Feb 27, 2025 |
| 4 | — | 0001415889-25-006234 | Mar 3, 2025 | Feb 27, 2025 |
| SCHEDULE 13G | — | 0000908834-25-000051 | Feb 7, 2025 | — |
| SCHEDULE 13G | — | 0002053997-25-000004 | Feb 5, 2025 | — |
| SCHEDULE 13G | — | 0001580642-25-000834 | Feb 5, 2025 | — |
| 4 | — | 0001415889-25-002823 | Feb 3, 2025 | Jan 31, 2025 |
| 4 | — | 0001415889-25-002821 | Feb 3, 2025 | Jan 31, 2025 |
| 4 | — | 0001415889-25-002820 | Feb 3, 2025 | Jan 31, 2025 |
| 4 | — | 0001415889-25-002819 | Feb 3, 2025 | Jan 31, 2025 |
| 4 | — | 0001415889-25-002818 | Feb 3, 2025 | Jan 31, 2025 |
| 4 | — | 0001415889-25-002817 | Feb 3, 2025 | Jan 31, 2025 |
| 4 | — | 0001415889-25-002816 | Feb 3, 2025 | Jan 31, 2025 |
| 4 | — | 0001415889-25-002815 | Feb 3, 2025 | Jan 31, 2025 |
| 4 | 4 | 0000950170-25-012403 | Feb 3, 2025 | Jan 31, 2025 |
| S-8 | S-8 | 0001193125-25-018558 | Feb 3, 2025 | — |
| 4 | — | 0001415889-25-002822 | Feb 3, 2025 | Jan 31, 2025 |
| 4 | — | 0001415889-25-002490 | Jan 31, 2025 | Jan 29, 2025 |
| 4 | — | 0001415889-25-002484 | Jan 31, 2025 | Jan 29, 2025 |
| 4 | — | 0001415889-25-002481 | Jan 31, 2025 | Jan 29, 2025 |
| 4 | — | 0001415889-25-002480 | Jan 31, 2025 | Jan 29, 2025 |
| 4 | — | 0001415889-25-002479 | Jan 31, 2025 | Jan 29, 2025 |
| 424B4 | 424B4 | 0001193125-25-017676 | Jan 31, 2025 | — |
| 8-K | 8-K | 0001193125-25-018471 | Jan 31, 2025 | — |
| 3 | — | 0001415889-25-002316 | Jan 29, 2025 | — |
| SEC STAFF LETTER | — | 9999999997-25-000290 | Jan 29, 2025 | — |
| EFFECT | — | 9999999995-25-000233 | Jan 29, 2025 | — |
| 3 | 3 | 0000950170-25-010733 | Jan 29, 2025 | — |
| 3 | — | 0001415889-25-002324 | Jan 29, 2025 | — |
| 3 | — | 0001415889-25-002323 | Jan 29, 2025 | — |
| 3 | — | 0001415889-25-002322 | Jan 29, 2025 | — |
| 3 | — | 0001415889-25-002321 | Jan 29, 2025 | — |
| 3 | — | 0001415889-25-002320 | Jan 29, 2025 | — |